Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wide Field OCTA in Ocular Diseases: a Prospective Observational Study of the Clinical Impact of Wide Field OCTA in Ocular Disease.

NCT07298174 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07298174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07298174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wide Field OCTA in Ocular Diseases: a Prospective Observational Study of the Clinical Impact of Wide Field OCTA in Ocular Disease.
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
May 31, 2028
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age - related macular degeneration (amd), best disease, central serous choroidopathy, diabetic macular edema, diabetic retinopathy, geographic atrophy, inherited retinal disease, macular neovascularisation, myopia, ocular surface disease, pachychoroid disease, retinal vein occlusion, retinitis pigmentosa (rp), stargardt disease, uveitis, vitreoretinal disease